PhRMA wins one in California

Share this article:
The Pharmaceutical Research and Manufacturers of America won a victory in last night's elections with the defeat of California Proposition 79, which would have imposed price controls on manufacturers participating in the state's Medi-Cal program and allowed individuals to sue companies for profiteering.
A rival ballot measure, the PhRMA-sponsored Proposition 78, was also voted down, 58-41 percent. PhRMA spent $72 million on an advertising, PR and direct-mail blitz to defeat Proposition 79, which lost by a margin of 61-38 percent. Backed by unions and consumer activists, the measure would have required drug companies to offer steep discounts to the uninsured in order to participate in Medi-Cal. By contrast, Proposition 78 would have encouraged companies to offer discounts voluntarily.
PhRMA's outlay on the campaign included $50 million in media spend and $13 million on glossy mailers, according to California press.
Share this article:
close

Next Article in News

Email Newsletters

More in News

Eli Lilly and BI's Jardiance hits shelves

Eli Lilly and BI's Jardiance hits shelves

The new SGLT-2 inhibitor is on shelves less than a month after FDA approval.

PhRMA Urges Court to Reject Off-Label Promotion Case

PhRMA Urges Court to Reject Off-Label Promotion Case

The Pharmaceutical Research and Manufacturers of America (PhRMA) says a California federal court should dismiss a whistleblower's False Claims Act suit against three drug companies on First Amendment grounds

Five things for Pharma Marketers to know: Tuesday, August 26

Five things for Pharma Marketers to know: Tuesday, ...

Merck and Pfizer pursue new pembrolizumab research, black box warnings are linked to fewer court visits, and the WHO says it needs $430M to fight Ebola.